Skip Navigation

Human Reproduction 2006 21(10):2721-2722; doi:10.1093/humrep/del104
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Vilos, G.A.
Right arrow Articles by Abu-Rafea, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Vilos, G.A.
Right arrow Articles by Abu-Rafea, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. 2721 For Permissions, please email: journals.permissions@oxfordjournals.org

Letters to the editor

Reply: Possibility of hidden damages with temporary uterine artery occlusion device

G.A. Vilos1, E.C. Vilos, W. Romano and B. Abu-Rafea

St Joseph’s Health Centre, University of Western Ontario, Ontario, Canada

1 To whom correspondence should be addressed at: St Joseph’s Health Centre, University of Western Ontario, 268 Grosvenor Street, London, Ontario, Canada. E-mail: george.vilos@sjhc.london.on.ca

The first 10% of the full text of this article appears below.

Sir,

Dr Palacios Jaraquemada raises concerns of ureteric and ovary damage following the treatment of women with symptomatic fibroids with temporary, Doppler-directed, transvaginal uterine artery occlusion with the flostat system (Vilos et al. 2006Go). At this stage in the system’s development, we have limited knowledge about the risks of either ureteric or ovarian damage. We are, however, pleased to share what we do know.

Ureter damage

From development work completed before the two pilot trials we have performed, it is known that the flostat clamp does not come into contact or apply pressure to the pelvic . . . [Full Text of this Article]

Ovary damage


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?